Autobio(SH:603658)2025-04-17 09:15Financial Performance - The company's operating revenue for Q1 2025 was CNY 995,933,663.32, representing a decrease of 8.56% compared to CNY 1,089,195,256.05 in the same period last year[4] - Net profit attributable to shareholders was CNY 269,880,235.57, down 16.76% from CNY 324,212,004.34 year-on-year[4] - Basic and diluted earnings per share were both CNY 0.47, reflecting a decrease of 16.07% compared to CNY 0.56 in the previous year[5] - The weighted average return on equity decreased by 0.65 percentage points to 3.09% from 3.74%[5] - Total operating revenue for Q1 2025 was ¥995,933,663.32, a decrease of 8.6% compared to ¥1,089,195,256.05 in Q1 2024[19] - Net profit for Q1 2025 was ¥273,079,722.47, a decline of 17.0% from ¥328,699,468.29 in Q1 2024[20] - The company reported a total comprehensive income of ¥273,067,610.47 for Q1 2025, down from ¥328,712,789.76 in Q1 2024[21] Cash Flow and Liquidity - The net cash flow from operating activities decreased by 49.35%, amounting to CNY 166,338,458.26, primarily due to a significant decline in sales receipts[8] - Cash received from sales of goods and services in Q1 2025 was ¥1,121,264,719.60, a decrease of 10.6% from ¥1,254,041,270.41 in Q1 2024[24] - The net cash flow from operating activities was $166,338,458.26, a decrease of 49.3% compared to $328,402,122.27 in the previous period[25] - The ending balance of cash and cash equivalents was $219,525,703.08, down from $1,077,430,057.76 year-over-year[27] - The company's cash and cash equivalents decreased to RMB 232,830,899.63 from RMB 465,373,123.02[14] Assets and Liabilities - Total assets at the end of the reporting period were CNY 11,968,031,676.54, an increase of 0.78% from CNY 11,875,065,943.97 at the end of the previous year[5] - Total liabilities decreased to ¥2,998,174,827.59 in Q1 2025 from ¥3,183,270,091.04 in Q1 2024, a reduction of 5.8%[17] - Accounts receivable stood at RMB 1,096,610,904.01, slightly down from RMB 1,138,995,430.17[15] - Inventory increased to RMB 1,170,654,495.92 from RMB 1,153,089,499.27[15] Shareholder Information - Shareholders' equity attributable to the parent company increased by 3.02% to CNY 8,876,936,827.16 from CNY 8,616,530,318.04[5] - The total number of ordinary shareholders at the end of the reporting period was 34,163[10] - The largest shareholder, Zhengzhou Antu Industrial Group Co., Ltd., holds 57.65% of the shares, totaling 329,445,773 shares[10] - The company has no related party relationships among the top ten shareholders, ensuring independent ownership structures[12] Future Outlook and Strategy - The company is focusing on expanding its market presence and enhancing product development strategies[12] - Future guidance and performance outlook will be provided in subsequent earnings calls[12] Expenses - Total operating costs for Q1 2025 were ¥746,443,403.96, down 4.0% from ¥777,943,233.44 in Q1 2024[19] - Research and development expenses for Q1 2025 were ¥130,563,085.75, down 13.7% from ¥151,149,747.29 in Q1 2024[20] - Cash outflow for purchasing goods and services was $373,420,356.81, up from $342,713,332.33 in the previous period[25] - Cash paid to employees increased to $476,776,379.07 from $434,312,784.10 year-over-year[25] - Cash paid for taxes decreased to $72,647,267.29 from $109,465,529.66 in the previous period[25] - Cash paid for other operating activities was $121,760,849.59, slightly up from $117,221,314.12 year-over-year[25]